ANURAG RELAN
Marriage and Family Therapists at Colorado Ave, Santa Monica, CA
License number
California A73796
Category
Osteopathic Medicine
Type
Family Medicine
Address
Address
2
1920 Colorado Ave, Santa Monica, CA 90404
File #2939, Los Angeles, CA 90074
File #2939, Los Angeles, CA 90074
Phone
(310) 319-4700
(310) 301-8709
(310) 301-8751 (Fax)
(310) 301-8709
(310) 301-8751 (Fax)
Professional information
Medical Director, Pharming Healthcare
Position:
Medical Director at Pharming
Location:
Greater Los Angeles Area
Industry:
Biotechnology
Work:
Pharming
since 2006
-
Medical Director
UCLA Medical Center
2002 - 2005
-
Clinical Instructor
Providence Medical Institute
- Manhattan Beach, CA 2002 - 2005
-
Physician
Education:
David Geffen School of Medicine at UCLA 1994 - 1999
MD University of California, Los Angeles 1996 - 1997
MPH, Health Services University of California, Berkeley 1990 - 1994
BA, Economics
MD University of California, Los Angeles 1996 - 1997
MPH, Health Services University of California, Berkeley 1990 - 1994
BA, Economics
Skills:
Clinical Development, Biotechnology, Clinical Research, FDA, Clinical Trials, Regulatory Affairs, Data Analysis, Medical Affairs, Lifesciences
Anurag Relan, Santa Monica CA
Specialties:
Family Physician
Address:
1920 Colorado Ave, Santa Monica, CA 90404
1010 N Sepulveda Blvd, Manhattan Beach, CA 90266
1010 N Sepulveda Blvd, Manhattan Beach, CA 90266
Education:
Doctor of Medicine
Board certifications:
American Board of Family Medicine Certification in Family Medicine
Treatment Of Bleeding With Low Half-Life Fibrinogen
US Patent:
2013026, Oct 10, 2013
Filed:
Feb 20, 2013
Appl. No.:
13/772292
Inventors:
- Leiden, NL
Anurag Relan - Los Angeles CA, US
Erik Jordahl Forsberg - Fitchburg WI, US
Anurag Relan - Los Angeles CA, US
Erik Jordahl Forsberg - Fitchburg WI, US
International Classification:
C07K 14/75
US Classification:
514 136
Abstract:
The invention provides low-half life fibrinogen as a result of recombinant expression or enzymatic and chemical removal. The low-half life fibrinogen is useful in treating or effecting prophylaxis of bleeding particularly in situations of an acute nature in which a high initial dose and rapid decline to normal or below normal levels is desirable.
Treatment Of Bleeding With Low Half-Life Fibrinogen
US Patent:
2011026, Oct 27, 2011
Filed:
Apr 29, 2009
Appl. No.:
12/990643
Inventors:
Frank Pieper - BH Heemstede, NL
Anurag Relan - Los Angeles CA, US
Erik Jordahl Forsberg - Fichburg WI, US
Anurag Relan - Los Angeles CA, US
Erik Jordahl Forsberg - Fichburg WI, US
Assignee:
Pharming Intellectual Property B.V. - Leiden
International Classification:
A61K 38/36, A61P 7/04
US Classification:
514 137
Abstract:
The invention provides low-half life fibrinogen as a result of recombinant expression or enzymatic and chemical removal. The low-half life fibrinogen is useful in treating or effecting prophylaxis of bleeding particularly in situations of an acute nature in which a high initial dose and rapid decline to normal or below normal levels is desirable.